Main Menu
Photo of Katherine C. Cooper

Katherine C. Cooper

  • ph: 202.326.7946
  • fx: 202.326.7999
  • Email
  • vCard


Co-Author, Predictable Materiality:  A Need for Common Criteria Governing the Disclosure of Clinical Trial Results by Publicly-Traded Pharmaceutical Companies, 29 J. Contemp. Health L. & Pol’y 201 (2013)

Co-Author, Deadly Experiments:  Imposing Discipline on New, Untested Lethal Injection Protocols, Florida Defender (Spring 2014)

Co-Author, Summary of Fraud and Abuse Statutes & Regulations:  North Carolina, The American Health Lawyers Association’s Fraud and Abuse Practice Group (Aug. 21, 2014)

Author, Can I See Some ID?  Banning Access to Cosmetic Breast Implant Surgery for Minors Under Eighteen, 27 J.L. & Health (2014)

Author, Injecting Caution:  A Need for Enhanced State-Level Enforcement Tactics Targeting the Cosmetic Use of Liquid Silicone Products, 30 J. Contemp. Health L. & Pol’y (2014)


Harvard Law School, J.D., magna cum laude, 2013

  • Line Editor and Digest contributor, Harvard Journal of Law & Technology, 2012-2013

Duke University, B.A., 2007


Law Clerk, Judge Allyson K. Duncan, U.S. Court of Appeals, Fourth Circuit, 2014-2015

Back to Page